The apex health research body ICMR is mulling a revision of its recommendation to use hydroxychloroquine (HCQ) for treatment of COVID-19 patients after doubts were raised over the effectiveness of the drug.
Asked if the government is planning to drop HCQ from the COVID-19 treatment plan and also as preventive medication, Head of Epidemiology and Communicable Diseases at ICMR, Dr Raman R Gangakhedkar on Wednesday said, "A decision in this regard will be taken following a review of all the evidences we are collecting."
Disclaimer: No Business Standard Journalist was involved in creation of this content